TekniPlex Healthcare set to acquire Seisa Medical.
TekniPlex Healthcare has initiated an agreement to purchase Seisa Medical. The acquisition is set to enhance the company’s capabilities in material science and process technologies, specifically focusing on minimally invasive and interventional therapy devices.
Seisa, headquartered in El Paso, Texas, operates as a medical device manufacturing company that offers services in design and development, component manufacturing, and final assembly. With over 2,000 employees, the company has established a presence across four facilities in the United States, Mexico, and Slovakia.
This move represents TekniPlex’s 20th acquisition in the last decade, as part of its strategy to foster business growth through transformative acquisitions and strategic additions.
“This is a transformative acquisition for TekniPlex Healthcare, moving us squarely into the CDMO (contract, development, and manufacturing organization) segment of MedTech for medical technologies,” TekniPlex CEO Chris Qualters told the press. “The ability for us to engage with our global customers on new medical technologies by developing engineered materials, co-designing components and assemblies, utilizing advanced process technologies and providing sterile barrier products allows us to truly partner with them from concept all the way to the point of care to help improve patient outcomes.”
Julio Chiu, Seisa founder and CEO, added, “Our customers count on us to deliver solutions for their most challenging applications. I am very confident that they will continue to count on us as TekniPlex Healthcare shares our same commitment to deliver better patient outcomes. We believe the combination of our two organizations will result in one of the most comprehensive value-added CDMO platforms in the industry.”